Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Walgreens chief executive's disclosure last week that VillageMD's doctor-staffed clinic expansion plan needed to go “on a diet” highlights certain risks in the race by retailers to open primary care centers across the country.

Cracks Appear In Walgreens Clinic Strategy As Patient Panels Go Unfilled

Amgen

Cisco Systems

Chevron

Dow Inc

Johnson & Johnson

Coca-Cola

Verizon

The 2024 Dogs of the Dow are particularly homely hounds—which means we're talking big dividends.

Dogs Of The Dow 2024: 10 Blue-Chip Dividend Payers

Even long-time dividend payers sometimes have to cut their dividends. Often, companies exhibit certain characteristics before they do a dividend cut.

So Your Dividend King Just Lost Its Crown. These 4 Warning Signs Might Have Saved You.

Walgreens announced solid revenue growth but also a steep earnings decline in its latest quarter. The company also cut its dividend for the first time in nearly half a century.

Why Walgreens Boots Alliance Stock Fell 4% This Week

Ending a 47-year streak of dividend increases, Walgreens has slashed its dividend. The annual dividend will fall by almost half -- from $1.92 per share to $1.00 per share.

Walgreens Boots Alliance Stock Just Slashed Its Dividend. Time to Buy?

The owner of Boots could be considering a £7bn London listing for the high street pharmacy company, reviving exit talks two years after a planned sale fell through. Tim Wentworth, the chief executive officer of Walgreens Boots Alliance Inc (NASDAQ:WBA), revealed “everything is on the table" when it comes to planning the next step for the UK retailer.

Boots mulls £7 billion London IPO

Procter & Gamble

The Dow 30 ended 2023 with a roughly 4.5% gain in December. Procter & Gamble was down 4.5% in the final month of 2023.

Is It Time to Buy the Dow Jones' 2 Worst-Performing December Stocks?

Given its better prospects, we believe Target stock (NYSE: TGT) is a better pick than Walgreens stock (NYSE: WBA). Although these companies are from different sectors, we compare them because they have a similar gross profit of around $27 billion, with sales of $139 billion for Walgreens and $109 billion for Target TGT.

After A 4% Fall Last Year Is Target A Better Pick Over Walgreens Stock?

Walgreens Boots Alliance is reporting mediocre results of growing sales but negative operating income - including first quarter results for fiscal 2024. From a technical point of view, Walgreens stock is at a major support level and the stock price is undervalued, making WBA worth a shot at this point. Nevertheless, Walgreens has to work on improving its balance sheet and turning the business around.

Walgreens Boots Alliance Q1 Earnings: A Glimmer Of Hope After All?

Walgreens cut its dividend, ending decades of increases. The reduction will enable it to retain more cash to fund growth and strengthen its balance sheet.

Walgreens Is Cutting Its Big-Time Dividend. Time to Buy the Beaten-Down Dow Stock?

Although the revenue and EPS for Walgreens (WBA) give a sense of how its business performed in the quarter ended November 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Walgreens (WBA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Drugstore chain Walgreens has been a disastrous addition to the Dow Jones Industrial Average. Alphabet and Amazon look like prime candidates to replace it.

Walgreens May Have Sped Its Exit From Dow Industrials With Dividend Cut

Walgreens Boots' (WBA) comparable pharmacy sales in the fiscal first quarter benefited from higher branded drug inflation and strong execution in pharmacy services.

Walgreens Boots (WBA) Q1 Earnings Top Estimates, Margins Down

Walgreens' dividend cut puts its membership in the elite Dividend Aristocrats in doubt.

Walgreens Slashes Dividend by Almost Half

Walgreens Boots Alliance announced better-than-expected fiscal 2024 Q1 results. However, the company also cut its dividend payout by 48%.

Why Walgreens Boots Alliance Stock Is Sinking Today

Lamb Weston Hlds

U.S. equities posted gains at midday as reports on record holiday online spending and a rise in private sector hiring boosted confidence about U.S. economic growth. The Dow, S&P 500, and Nasdaq all gained.

Midday Movers: Lamb Weston Climbs on Raised Guidance, Walgreens Slides After Dividend Cut

Boeing

Salesforce

Disney

Goldman Sachs

Intel

McDonald's

Microsoft

NIKE

Walmart

"The Dow® [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors. Sector representation.is also a consideration.” – Dow Jones & Co. The highest-yield 10 stocks are December's Dogs of the Dow: JNJ, AMGN, KO, CSCO, CVX, IBM, DOW, MMM, VZ, and WBA. They only averaged a 4.49% annual yield, as prices. Thirty Dow stocks represent nine of eleven sectors. Dow Jones tracks utilities as a separate index and omits real estate. Broker top-ten target-estimated December net gains ranged 10.25%-22.59%, topped by CVX 1/2/24.

January Dogs Of The Dow: 2 Buyable, 6 Watchable

Walgreens Boots Alliance (WBA) shares tumbled over 6% in early trading Thursday as the biggest U.S. pharmacy chain slashed its dividend nearly in half, and said it would use the money for other purposes as it faced a “challenging consumer backdrop.”

Walgreens Sinks After an Earnings Beat—Here's Why

Walgreens Boots Alliance, Inc. (WBA) Q1 2024 Earnings Call Transcript

Walgreens Boots Alliance NYSE: WBA is the ugliest dog of them all. This Dow stock fell 31% for the year, making it the worst-performing member of the index.

Walgreens Boots Alliance: Is it time to take this Dog for a walk?

Walgreens Boots Alliance (WBA) came out with quarterly earnings of $0.66 per share, beating the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $1.16 per share a year ago.

Walgreens Boots Alliance (WBA) Tops Q1 Earnings and Revenue Estimates

Walgreens Boots Alliance, Inc. has announced a nearly 50% dividend cut, disappointing dividend investors. Despite the dividend cut, the stock is trending up pre-market, possibly due to positive Q1 results. There were warning signs of Walgreens' struggles, including a long-term decline in stock performance and a high yield that quadrupled in four years.

Walgreens Slashes Dividend: A Postmortem

Walgreens (NASDAQ: WBA ) is one of the top-trending tickers on websites and social media today after the company announced that it would cut its dividend nearly in half. The firm also released better-than-expected results for its fiscal first quarter.

WBA Stock Alert: Walgreens Just Slashed Its Dividend

Walgreens Boots Alliance's U.S. retail pharmacy unit brought in revenue of $28.94 billion in the first quarter, topping analysts' average estimate of $27.26 billion.

Walgreens quarterly profit beat helped by higher drug prices, cost cuts

Walgreens Boots Alliance Inc (NASDAQ: WBA) is trending up in premarket today even though it reported a net loss for its fiscal Q1 and trimmed its dividend nearly in half. Walgreens has paid dividend for 91 years The multinational announced 25 cents per share of quarterly dividend on Thursday – down from 48 cents.

News for Walgreens Stock (WBA)